{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2662,"total_is_capped":false,"direct_labels_cover":9,"predictions_cover":2662,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"e35836d64375","filters":{"topic":"Virus-based gene therapy research"}},"results":[{"id":"W2014356856","doi":"10.1038/nrg1066","title":"Progress and problems with the use of viral vectors for gene therapy","year":2003,"lang":"en","type":"review","venue":"Nature Reviews Genetics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2501,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institutes of Health; Hospital for Sick Children; University of Pennsylvania","keywords":"Genetic enhancement; Disease; Biology; Viral vector; Intensive care medicine; Vector (molecular biology); Gene; Bioinformatics; Medicine; Genetics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08747092378967157,"gpt":0.379828555871552,"spread":0.2923576320818804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000711782,0.0006044335,0.001365351,0.00007998737,0.0001023307,0.00006200502,0.0005343462,0.0008724565,0.000005086801],"category_scores_gemma":[0.00005342547,0.0003155867,0.000475312,0.0002836985,0.00032447,0.000003152752,0.0000910225,0.0005811345,0.000001438279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002021768,"about_ca_system_score_gemma":0.0003366783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":5.912927e-7,"about_ca_topic_score_gemma":0.00002004139,"domain_scores_codex":[0.9974261,0.0006036048,0.0005941397,0.0006705835,0.0002829531,0.0004226276],"domain_scores_gemma":[0.997924,0.00007107273,0.0005752319,0.001086763,0.0002415269,0.0001013968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00015374,0.00005849548,0.000009949074,0.006182575,0.0003518318,6.644549e-7,0.00001226959,0.000003877075,0.0005744045,0.000006089952,0.002362178,0.9902839],"study_design_scores_gemma":[0.0003852241,0.002792209,0.000001150833,0.001300755,0.0002976076,0.00003130225,8.762972e-7,0.000002002436,0.002209261,0.000004005546,0.9926043,0.0003713678],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004934419,0.9929191,0.00008068434,0.00003436799,0.00008377337,0.006247866,0.0001281635,0.000005649188,0.000006948221],"genre_scores_gemma":[0.000009917917,0.9946268,0.003206592,0.000200378,0.0002428156,0.001025027,0.0002905062,0.0001391984,0.0002588272],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9902421,"threshold_uncertainty_score":0.9999296,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211238487","doi":"10.1038/nbt.2287","title":"Oncolytic virotherapy","year":2012,"lang":"en","type":"review","venue":"Nature Biotechnology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1407,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jennerex Biotherapeutics (Canada); Ottawa Hospital","funders":"National Cancer Institute","keywords":"Oncolytic virus; Virotherapy; Medicine; Herpes simplex virus; Virus; Virology; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.02838608479761467,"gpt":0.3700823087279255,"spread":0.3416962239303108,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.000402813,0.0006210152,0.001121406,0.0004188977,0.00009265463,0.00002179278,0.001253418,0.009058973,0.0001600869],"category_scores_gemma":[0.00008375351,0.0005101986,0.000544587,0.0005012246,0.0003005445,0.000002352131,0.0003387282,0.002540111,0.0003803652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001154141,"about_ca_system_score_gemma":0.0004344866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002206112,"about_ca_topic_score_gemma":0.00004233827,"domain_scores_codex":[0.9974411,0.0002238225,0.0004132784,0.0008711307,0.0002492346,0.0008014602],"domain_scores_gemma":[0.9979067,0.00003164975,0.0002365557,0.001629922,0.00005870792,0.0001364487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001110815,0.00007867673,5.781437e-7,0.0008160019,0.000309242,0.000008094575,0.000001639411,5.395265e-8,0.004867131,0.0002078311,0.001860373,0.9917393],"study_design_scores_gemma":[0.0002514685,0.001338548,2.323485e-7,0.0003125724,0.0001624094,0.0001249916,0.00000203445,2.221041e-7,0.01283929,0.00003038928,0.9844378,0.0005000596],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008012528,0.99748,0.00003417804,0.0002164871,0.000530395,0.0009299119,0.00006660969,0.0001128134,0.0005495112],"genre_scores_gemma":[0.0001084938,0.9959757,0.0002438246,0.0003138366,0.001132924,0.0001983697,0.0003681355,0.0001799253,0.001478739],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9912392,"threshold_uncertainty_score":0.999761,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130314959","doi":"10.1093/nar/30.2.e9","title":"High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells","year":2002,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1053,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"National Research Council Canada; Biotechnology Research Institute","funders":"","keywords":"Biology; Transfection; Molecular biology; Green fluorescent protein; HEK 293 cells; Cell culture; Expression vector; Plasmid; Reporter gene; Viral vector; Recombinant DNA; Polyethylenimine; Gene expression; Gene; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.04660526851841845,"gpt":0.3111994248175253,"spread":0.2645941562991068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001620117,0.0002330246,0.0002849564,0.000222162,0.0004297658,0.00004938852,0.0003089493,0.0002771244,0.0002674458],"category_scores_gemma":[0.00008281801,0.0002239108,0.0000919962,0.0004426357,0.0004656166,0.00002876272,0.0001026534,0.0005073402,0.00002803623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007852184,"about_ca_system_score_gemma":0.00005388699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003115835,"about_ca_topic_score_gemma":0.0001286624,"domain_scores_codex":[0.9966294,0.0006117377,0.0003918267,0.000824986,0.0008600127,0.0006820695],"domain_scores_gemma":[0.9987081,0.00002088929,0.00005669548,0.0006539209,0.0003855605,0.0001748697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000694333,0.0003818728,0.00002831859,0.0001089627,0.00005777743,0.000004527856,0.0002075048,0.00002351208,0.9714314,0.000060914,0.005257858,0.02174305],"study_design_scores_gemma":[0.001273669,0.005439162,0.0001821368,0.00006276866,0.000009108641,0.000008793534,0.0001182704,0.00005964423,0.9865954,0.000179476,0.005845349,0.0002262589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962376,0.0006515033,0.0002120899,0.001221628,0.0001460769,0.001271656,0.00003024934,0.00002309401,0.0002061352],"genre_scores_gemma":[0.9953826,0.000835864,0.0004423769,0.00002540671,0.0001798112,0.0001155179,0.00006641323,0.00007011576,0.002881876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02151679,"threshold_uncertainty_score":0.9130819,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968368569","doi":"10.1038/srep00415","title":"Quantitative assessment on the cloning efficiencies of lentiviral transfer vectors with a unique clone site","year":2012,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1027,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Insert (composites); Cloning (programming); Mutagenesis; clone (Java method); Computational biology; Biology; Transgene; Mutant; Vector (molecular biology); Viral vector; Recombinant DNA; Ligation; Site-directed mutagenesis; In vitro recombination; Molecular biology; Gene; Genetics; Molecular cloning; Computer science; Gene expression; Materials science","retraction":null,"screen_n_in":null,"score":{"opus":0.02858795714365216,"gpt":0.31713598399041,"spread":0.2885480268467579,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002469018,0.0001381408,0.0001364492,0.00008560623,0.0002397229,0.00005882006,0.0001459956,0.00005449628,0.00004009707],"category_scores_gemma":[0.00006511338,0.00008498033,0.00008569822,0.0003409185,0.0005382326,0.00001002826,0.00004620282,0.0001272401,0.000004487884],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002394785,"about_ca_system_score_gemma":0.0002302164,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001766022,"about_ca_topic_score_gemma":0.0000762068,"domain_scores_codex":[0.9982508,0.0001983618,0.0002472976,0.0003952391,0.000535872,0.0003723989],"domain_scores_gemma":[0.9989424,0.00004208341,0.0000978819,0.0006700418,0.0001714045,0.00007623001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003272132,0.0001606858,0.008736311,0.00001023303,0.00004797947,0.000009101712,0.0005333025,0.0003026627,0.9889147,0.0004248384,0.0003944113,0.0001386139],"study_design_scores_gemma":[0.0001345521,0.001771715,0.002717976,0.00002645001,0.0000124121,0.00002102205,0.0003246447,0.00003654962,0.9927645,0.00005820142,0.00200675,0.0001252673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966124,0.000250989,0.001183541,0.0001028721,0.0004715003,0.0003470161,0.000005758329,0.000009169024,0.001016747],"genre_scores_gemma":[0.9988791,0.00000764702,0.0002837504,0.00003628443,0.000037859,0.000033108,0.00004327423,0.00001761407,0.0006613386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006018335,"threshold_uncertainty_score":0.3465397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150701651","doi":"10.1016/s1535-6108(03)00241-1","title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","year":2003,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":848,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal; McGill University; Terry Fox Research Institute; University of Ottawa; Ottawa Regional Cancer Foundation","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Oncolytic virus; Vesicular stomatitis virus; Innate immune system; Lytic cycle; Ovarian cancer; Biology; Cancer; Interferon; Immunity; Cancer cell; Clearance; Cancer research; Immune system; Immunology; Vesicular Stomatitis; Virology; Virus; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02368840543473547,"gpt":0.2937026590417071,"spread":0.2700142536069716,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003775383,0.0002373333,0.000242375,0.00004917469,0.0000795715,0.00002544448,0.0003105843,0.000131422,0.0001473666],"category_scores_gemma":[0.00002102556,0.0001954794,0.00006913132,0.0002365806,0.00007440354,0.000005581541,0.00007509794,0.0001969392,0.0000100491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002537958,"about_ca_system_score_gemma":0.0003698797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003980999,"about_ca_topic_score_gemma":0.004361222,"domain_scores_codex":[0.9983277,0.0002917986,0.0002055521,0.0005001361,0.0001875748,0.000487245],"domain_scores_gemma":[0.9989629,0.000007769946,0.00008267585,0.0006525686,0.0001273151,0.0001667749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005210759,0.0001357519,0.04933688,0.0001460865,0.00004283309,0.000007072657,0.0002378473,0.004406401,0.943693,0.000001493247,0.0001990282,0.001272533],"study_design_scores_gemma":[0.001412267,0.0007202753,0.02194222,0.00009503969,0.000009299316,0.00000311276,0.0004492923,0.00002104621,0.9735671,0.000005797789,0.001469665,0.0003048385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939381,0.004210411,0.00004709054,0.00005969965,0.000109768,0.0006500394,0.0001248285,0.00001250704,0.0008475234],"genre_scores_gemma":[0.9976166,0.001257803,0.00002120793,0.00042672,0.00006015492,0.0002419377,0.00002139114,0.00004093547,0.0003131808],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02987415,"threshold_uncertainty_score":0.7971419,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1542691850","doi":"10.1038/77558","title":"Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus","year":2000,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":816,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; University of Ottawa; Ottawa Regional Cancer Foundation","funders":"National Cancer Institute","keywords":"Oncolytic virus; Vesicular stomatitis virus; Interferon; Biology; Virus; Virology; Cancer research; Melanoma; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.01293234050267385,"gpt":0.2836048354531752,"spread":0.2706724949505013,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008124479,0.0002201473,0.0002253108,0.00008201045,0.0000762135,0.0000180435,0.0004465314,0.0001847249,0.0003350531],"category_scores_gemma":[0.00007947388,0.0001251134,0.00004652411,0.0003512882,0.0001791818,0.000004582837,0.00003251646,0.0007877625,0.00002447624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004802119,"about_ca_system_score_gemma":0.00009284449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002546192,"about_ca_topic_score_gemma":0.001039927,"domain_scores_codex":[0.9982676,0.0002460148,0.000222911,0.000419023,0.0004231151,0.0004213663],"domain_scores_gemma":[0.9991867,0.00006254406,0.00005321806,0.0005519231,0.00005900762,0.00008661384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007400198,0.0002084343,0.0005736647,0.0000566072,0.00005396659,0.0002940891,0.001535555,0.00006694427,0.908871,0.00007160254,0.004122738,0.07674519],"study_design_scores_gemma":[0.006790907,0.02693461,0.002043423,0.0007377012,0.00003492759,0.0003645406,0.0009294041,0.0000557288,0.624459,0.0001195927,0.3369363,0.0005938939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9795663,0.01332389,0.00001899496,0.0007912969,0.000061908,0.0005032117,0.000002841838,0.00001641181,0.005715131],"genre_scores_gemma":[0.9952368,0.0008242342,0.00003709075,0.002568434,0.000684738,0.00007758101,0.00005387737,0.00003644923,0.000480823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3328135,"threshold_uncertainty_score":0.5101975,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2170205772","doi":"10.1086/595830","title":"Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses","year":2009,"lang":"en","type":"article","venue":"The Journal of Infectious Diseases","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":792,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Genetics; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Vlaamse regering; University of Pennsylvania; GlaxoSmithKline; National Institutes of Health; International AIDS Vaccine Initiative","keywords":"Virology; Antibody; Adeno-associated virus; Neutralization; Neutralizing antibody; Transduction (biophysics); Biology; Serotype; Recombinant DNA; Virus; Immunology; Gene; Genetics; Vector (molecular biology)","retraction":null,"screen_n_in":null,"score":{"opus":0.02829089295095816,"gpt":0.3453113912022825,"spread":0.3170204982513244,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000925927,0.0001419511,0.0003384515,0.0001427656,0.0001063495,0.000006973719,0.0003294703,0.00006706826,0.00002338496],"category_scores_gemma":[0.001538278,0.00009737825,0.0002107042,0.0002082171,0.000118805,0.000007473966,0.0000514719,0.0001453655,0.000004652061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003107578,"about_ca_system_score_gemma":0.0001297243,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002443422,"about_ca_topic_score_gemma":0.0001082715,"domain_scores_codex":[0.9983315,0.0006207711,0.0004770598,0.000112967,0.0001666923,0.000290975],"domain_scores_gemma":[0.9986621,0.0002350556,0.0003898123,0.0002569029,0.0003016627,0.0001544442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004514926,0.0005158531,0.3132351,0.00001780195,0.0004928836,0.00001042873,0.0001882432,0.005881234,0.6644425,0.00005411023,0.006204749,0.004442233],"study_design_scores_gemma":[0.002051094,0.01971112,0.5610036,0.0001832754,0.0003168214,0.0001223143,0.0002041394,0.00001743021,0.4114306,0.003325731,0.00123746,0.0003964536],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923976,0.006395846,0.000164724,0.0006564535,0.00009843172,0.0001216686,0.00001913494,0.000009105454,0.000137024],"genre_scores_gemma":[0.996428,0.001216396,0.00002564319,0.002039161,0.0002259254,0.0000014685,0.000003944811,0.00001423733,0.00004522787],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2530119,"threshold_uncertainty_score":0.397097,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093059993","doi":"10.1038/nm.3089","title":"Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer","year":2013,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":776,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; McMaster University Medical Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Oncolytic virus; Medicine; Hepatocellular carcinoma; Immunotherapy; Response Evaluation Criteria in Solid Tumors; Oncology; Liver cancer; Vaccinia; Cancer; Internal medicine; Immunology; Progressive disease; Chemotherapy; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04725313944558889,"gpt":0.4274561262808125,"spread":0.3802029868352236,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002462331,0.000200916,0.0007898473,0.0001565594,0.00003022477,0.000007310759,0.0003554039,0.0005941095,0.0008535928],"category_scores_gemma":[0.0008029543,0.0001395323,0.0001980961,0.0002533753,0.0002796558,0.000004909767,0.00006508657,0.0007548576,0.00001762141],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003371267,"about_ca_system_score_gemma":0.0002391874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002973793,"about_ca_topic_score_gemma":0.0003079119,"domain_scores_codex":[0.997524,0.0006365448,0.000764703,0.0003754192,0.0003758362,0.0003234893],"domain_scores_gemma":[0.9986905,0.000350103,0.0002225004,0.0004624285,0.0001755147,0.00009893415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6739853,0.0001905746,0.0004979151,0.00003341855,0.0002587014,0.000005270974,0.0001154995,0.000004965317,0.2963583,0.00001747767,0.001346977,0.02718564],"study_design_scores_gemma":[0.9244065,0.005747391,0.002221601,0.0001639469,0.00008922948,0.000003827882,0.00005565111,0.0002967502,0.06320504,0.0001284949,0.003455123,0.0002263924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9736559,0.02171198,0.00001413527,0.001678267,0.0006498505,0.001580303,0.000002859354,0.000008208721,0.0006984291],"genre_scores_gemma":[0.9900364,0.00662574,0.00005008018,0.001228822,0.001173168,0.000192392,0.00002580376,0.00003242712,0.0006351634],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2504213,"threshold_uncertainty_score":0.9346243,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W140890592","doi":"10.1385/0-89603-178-0:109","title":"Manipulation of Adenovirus Vectors","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":760,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Virology; DNA; Transcription (linguistics); RNA; Serotype; Mastadenovirus; Computational biology; Genetics; Adenoviridae; Gene; Genetic enhancement","retraction":null,"screen_n_in":null,"score":{"opus":0.06752512191773838,"gpt":0.3184505191735036,"spread":0.2509253972557652,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001609285,0.00009713178,0.00009596939,0.00003950472,0.00004873014,0.00001078366,0.0001486909,0.00008430808,0.00004554184],"category_scores_gemma":[0.00002617794,0.00009829565,0.00005941957,0.00001226363,0.00007022254,0.000001348738,0.0000369645,0.00006070061,0.000004383622],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008275041,"about_ca_system_score_gemma":0.00003613568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003686467,"about_ca_topic_score_gemma":0.00009094564,"domain_scores_codex":[0.9992071,0.0001027674,0.0001533263,0.0002033611,0.0001549246,0.0001785538],"domain_scores_gemma":[0.9994604,0.000006228459,0.00005796964,0.0003673855,0.00006111529,0.00004690579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004656384,0.00004779702,0.000129104,0.00003649748,0.00008862879,0.00000278222,0.0001216168,0.0001530299,0.9837538,0.004882231,0.000654577,0.009664275],"study_design_scores_gemma":[0.0003908038,0.0005940102,0.0002239588,0.000005446661,0.000008815874,0.000002047834,0.000009668992,0.00001311207,0.9541217,0.0001677512,0.04435435,0.0001083488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9487134,0.002918988,0.000178556,0.00000235479,0.00007040528,0.0002118166,0.0000057114,0.00001213475,0.04788659],"genre_scores_gemma":[0.9966176,0.00007872366,0.00008196772,0.00003737702,0.00006333765,0.00001983662,0.00001559316,0.00002296117,0.003062643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04790412,"threshold_uncertainty_score":0.400838,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3111331330","doi":"10.1016/j.ymthe.2020.12.007","title":"Current Clinical Applications of In Vivo Gene Therapy with AAVs","year":2020,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":745,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Eye Institute; National Heart, Lung, and Blood Institute; Pfizer Canada; Canadian Institutes of Health Research; Novartis; Amicus Therapeutics; Sarepta Therapeutics; National Institutes of Health; Pfizer","keywords":"Genetic enhancement; Medicine; Choroideremia; Spinal muscular atrophy; Bioinformatics; Disease; Pathology; Biology; Genetics; Ophthalmology; Gene; Retinal","retraction":null,"screen_n_in":null,"score":{"opus":0.0671737211929952,"gpt":0.4214098242799977,"spread":0.3542361030870025,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005391619,0.0005844468,0.00149886,0.0001922054,0.00003967944,0.00002531826,0.0009670304,0.0004508509,0.00006079829],"category_scores_gemma":[0.00001770945,0.0004534099,0.0007277807,0.0006673392,0.0002267639,0.000002685363,0.000114921,0.0005847634,0.00002542462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003813605,"about_ca_system_score_gemma":0.0009559359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006049562,"about_ca_topic_score_gemma":0.00001882807,"domain_scores_codex":[0.9964152,0.0007593858,0.0009705188,0.001002625,0.0004212283,0.000431038],"domain_scores_gemma":[0.9979157,0.00003753804,0.0004265552,0.00128885,0.0001409181,0.0001904515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009570641,0.0004595894,0.00003698858,0.0004234615,0.0004868114,0.00001918422,0.00001626104,0.0000047162,0.01133346,0.00001376755,0.00009073913,0.986158],"study_design_scores_gemma":[0.001475283,0.003433202,0.000003297997,0.000402158,0.00004167904,0.00001195299,0.000002863735,0.000002337238,0.03147408,0.00002313333,0.962685,0.0004449417],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002686667,0.9927468,0.001787929,0.00004501876,0.00005894184,0.002449833,0.0001005521,0.00001811177,0.0001060936],"genre_scores_gemma":[0.0002650319,0.9974149,0.0003352447,0.0001875278,0.0002809679,0.000982894,0.0003032009,0.0001760197,0.00005417334],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.985713,"threshold_uncertainty_score":0.9997917,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029613356","doi":"10.1007/s00705-013-1914-1","title":"The family Parvoviridae","year":2013,"lang":"en","type":"article","venue":"Archives of Virology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":689,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"National Science Foundation; National Institutes of Health; National Cancer Institute; National Institute of General Medical Sciences; Medical Research Council; National Institute of Allergy and Infectious Diseases; Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Virus classification; Nomenclature; Subfamily; Phylogenetic tree; Taxonomy (biology); Context (archaeology); Human virome; Taxon; Evolutionary biology; Zoology; Genetics; Ecology; Genome","retraction":null,"screen_n_in":null,"score":{"opus":0.009946716810004804,"gpt":0.2649691693821204,"spread":0.2550224525721156,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001184087,0.00009145748,0.0001007583,0.00003295751,0.00009803967,0.00001007485,0.0004242673,0.00005850777,0.00003720996],"category_scores_gemma":[0.00005074958,0.00006371152,0.00007969906,0.00003760321,0.0005652906,0.000001439127,0.0001567636,0.00009443585,0.00008493911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001372918,"about_ca_system_score_gemma":0.00004946227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004890081,"about_ca_topic_score_gemma":0.00008617994,"domain_scores_codex":[0.9990928,0.0001766508,0.0001599365,0.0001950406,0.00008194064,0.0002936122],"domain_scores_gemma":[0.9992886,0.0001179166,0.00005311113,0.0004603578,0.00002160759,0.00005841045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005625488,0.00002644087,0.0007373607,0.000002698041,0.00005118414,4.173194e-7,0.0000356257,0.00002121011,0.9577282,0.0001813678,0.002375775,0.03827718],"study_design_scores_gemma":[0.0010371,0.006028274,0.06982652,0.000004218982,0.00001023921,0.00001071513,0.0001530743,0.0003141416,0.8106925,0.007034606,0.1046616,0.0002270611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887546,0.00224996,0.0002083745,0.0008508803,0.00005544478,0.000184028,0.000004527586,0.000006026415,0.007686192],"genre_scores_gemma":[0.9972737,0.0009522527,0.0002096472,0.0005185794,0.00009172907,0.00005636461,0.00001437781,0.00001525434,0.0008680555],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1470357,"threshold_uncertainty_score":0.259808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149731696","doi":"10.1016/s1474-4422(10)70254-4","title":"Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial","year":2010,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":680,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"UCB Pharma; U.S. Food and Drug Administration; Schering-Plough; National Institutes of Health; H. Lundbeck A/S; Teva Pharmaceutical Industries; Pfizer; Michael J. Fox Foundation for Parkinson's Research","keywords":"Neurturin; Medicine; Clinical endpoint; Consolidated Standards of Reporting Trials; Adverse effect; Randomized controlled trial; Clinical trial; Internal medicine; Surgery; Neurotrophic factors; Glial cell line-derived neurotrophic factor","retraction":null,"screen_n_in":null,"score":{"opus":0.03476311458167437,"gpt":0.3135376124543153,"spread":0.2787744978726409,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009691371,0.0001998928,0.0005541702,0.00005593176,0.0001048445,0.00001675029,0.0006799223,0.0001898661,0.00004823666],"category_scores_gemma":[0.0002372087,0.0001385703,0.000313995,0.00007137697,0.0002792426,0.000003050372,0.000128157,0.0003169799,0.000007003432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000002189131,"about_ca_system_score_gemma":0.0001782017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000759605,"about_ca_topic_score_gemma":0.0001491717,"domain_scores_codex":[0.9982587,0.0003467307,0.0003313358,0.0004168984,0.0001738985,0.0004724287],"domain_scores_gemma":[0.9983759,0.0002887153,0.0001822294,0.000897512,0.0001379105,0.0001177264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6318261,0.00008836322,0.00008340308,0.000008644529,0.00009853802,0.00000392744,0.000006414906,0.00005205378,0.3664601,0.00003790405,0.0009383603,0.0003961635],"study_design_scores_gemma":[0.8111575,0.003875475,0.000135123,9.302787e-7,0.00007147087,0.000009576416,0.000001120831,0.0001566164,0.1525927,0.0002106186,0.0316522,0.0001366659],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911222,0.0006207719,0.00005522883,0.003394905,0.0006464647,0.003931122,0.00006184509,0.00001756782,0.0001498784],"genre_scores_gemma":[0.993763,0.0003448213,0.00006178251,0.001865876,0.002203094,0.001417111,0.00007149988,0.00004043277,0.0002323262],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2138674,"threshold_uncertainty_score":0.5650731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011513757","doi":"10.1038/nrc3770","title":"Going viral with cancer immunotherapy","year":2014,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":588,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital; Children's Hospital of Eastern Ontario; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Immune system; Immunotherapy; Cancer immunotherapy; Cancer; Cancer research; Immunology; Immunogenic cell death; Medicine; Antigen; Cancer cell; Immune checkpoint; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02561838132782282,"gpt":0.4041598546030732,"spread":0.3785414732752503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007641038,0.0009025583,0.002431756,0.0001340405,0.0001085536,0.00006822258,0.0009659863,0.001373978,0.0003391514],"category_scores_gemma":[0.00005622082,0.0005848556,0.0008967929,0.0004249303,0.0001385986,0.000005929993,0.0001250237,0.001653887,0.00007420274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002317228,"about_ca_system_score_gemma":0.00116534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003297264,"about_ca_topic_score_gemma":0.0005746169,"domain_scores_codex":[0.9964216,0.0006284846,0.0007115075,0.001089777,0.0004403931,0.0007081862],"domain_scores_gemma":[0.9976554,0.00003797228,0.000631056,0.001333925,0.000176969,0.000164714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000255583,0.00002294514,0.000005238334,0.009302268,0.0005261815,0.000003254077,0.000005562196,0.000002344155,0.0004040507,0.000008198152,0.01326458,0.9761998],"study_design_scores_gemma":[0.0004341439,0.0006711839,6.410622e-7,0.01448471,0.0003317129,0.00001800565,4.97525e-7,8.292402e-7,0.0004450404,0.000002789455,0.9828643,0.0007460964],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002627938,0.996895,0.00003257857,0.0000729456,0.0004909086,0.001942541,0.0001541419,0.00004003795,0.0003456288],"genre_scores_gemma":[0.000005461178,0.9909438,0.0001543628,0.001300485,0.002366688,0.002255688,0.0003503416,0.000355056,0.002268085],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9754537,"threshold_uncertainty_score":0.9999225,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135907949","doi":"10.1016/s1474-4422(08)70065-6","title":"Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial","year":2008,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":587,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Neurturin; Tolerability; Medicine; Adverse effect; Adeno-associated virus; Dyskinesia; Internal medicine; Parkinson's disease; Neurotrophic factors; Clinical trial; Disease; Oncology; Glial cell line-derived neurotrophic factor; Vector (molecular biology); Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03740364909792256,"gpt":0.3094398217889936,"spread":0.2720361726910711,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005581367,0.0001897064,0.0005006975,0.00004639033,0.0001435772,0.0000121692,0.0006686784,0.0001224315,0.00001444378],"category_scores_gemma":[0.0001500074,0.0001412759,0.00002843404,0.000187296,0.0004008059,0.00001134017,0.0003248639,0.0002291031,0.000001171846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009414776,"about_ca_system_score_gemma":0.0001752423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007942251,"about_ca_topic_score_gemma":0.0003080782,"domain_scores_codex":[0.9976871,0.0008951005,0.0003403247,0.0004816647,0.0002391094,0.0003566848],"domain_scores_gemma":[0.9986652,0.00004391461,0.0001956378,0.000732034,0.0001976306,0.0001656115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8314055,0.002304021,0.03704895,0.00003106878,0.0001129754,0.00002235234,0.0001099256,0.0001094567,0.1257681,0.000006933775,0.0001340197,0.002946744],"study_design_scores_gemma":[0.1945831,0.2060549,0.4780343,0.00003877665,0.0001439333,0.00002735,0.00001059317,0.0003011615,0.1157926,0.0001083637,0.004235015,0.0006698826],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979165,0.0003515738,0.00001534414,0.0004096715,0.00006921571,0.0009751711,0.0002315548,0.000009999078,0.00002102869],"genre_scores_gemma":[0.9982897,0.0005156525,0.00002072194,0.0008887424,0.0001306474,0.00003762858,0.0000752588,0.00002709702,0.00001457436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6368223,"threshold_uncertainty_score":0.5761064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965497380","doi":"10.1038/nature10358","title":"Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans","year":2011,"lang":"en","type":"article","venue":"Nature","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":550,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; University of Ottawa; Wilfrid Laurier University; Ottawa Hospital; Western University; Jennerex Biotherapeutics (Canada)","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Transgene; Cancer; Cancer research; Small interfering RNA; Biology; Cancer cell; Virotherapy; Virus; Systemic administration; Virology; Cell culture; Gene; Transfection; In vivo; Biotechnology","retraction":null,"screen_n_in":null,"score":{"opus":0.02466228104683347,"gpt":0.3087834715548646,"spread":0.2841211905080311,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001819299,0.0001404209,0.0001745642,0.000102596,0.00003314793,0.000004597042,0.000306786,0.0008121516,0.0001616189],"category_scores_gemma":[0.00005531284,0.0001361012,0.00006779509,0.0001721734,0.00006357845,0.000002445725,0.00007164068,0.0007448571,0.000008407961],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004668557,"about_ca_system_score_gemma":0.0002326134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003674429,"about_ca_topic_score_gemma":0.005015461,"domain_scores_codex":[0.9989879,0.00007755449,0.0001875089,0.0002976849,0.0001635094,0.0002858682],"domain_scores_gemma":[0.999408,0.000009015835,0.00006625641,0.0003255829,0.0001249488,0.00006616824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001476461,0.0002573043,0.001030889,0.00003401888,0.00005691767,0.00002469604,0.0002678728,0.00002502832,0.9919994,0.00003528697,0.0001576721,0.004634403],"study_design_scores_gemma":[0.001245322,0.001785744,0.005555504,0.00003230715,0.00001443948,0.000002784215,0.00007517828,0.0001419394,0.9902185,0.0001051949,0.0006308222,0.0001922458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929049,0.006236483,0.00005244494,0.00002408338,0.0001273706,0.000256924,0.00006108528,0.000009327657,0.0003273793],"genre_scores_gemma":[0.9982354,0.0005361217,0.0005026842,0.0003140959,0.00007704668,0.0000341312,0.00003595705,0.00002797622,0.0002365783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005700362,"threshold_uncertainty_score":0.6264057,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090732350","doi":"10.1038/nrc1750","title":"Recent progress in the battle between oncolytic viruses and tumours","year":2005,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":536,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Novelty; Battle; Clinical trial; Virotherapy; Virology; Medicine; Virus; Internal medicine; History; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.07766616528571875,"gpt":0.4575365561396724,"spread":0.3798703908539537,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001292729,0.0005061007,0.001365624,0.0001109857,0.00007984006,0.00006093298,0.0007836318,0.0008691765,0.0000725034],"category_scores_gemma":[0.00020434,0.0003008637,0.000323856,0.00048677,0.0001649602,0.000004602774,0.000152637,0.001410158,0.00003142842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001832335,"about_ca_system_score_gemma":0.000553801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003632569,"about_ca_topic_score_gemma":0.0003725113,"domain_scores_codex":[0.997025,0.0008767958,0.0006007283,0.0006926901,0.0003401533,0.0004646834],"domain_scores_gemma":[0.9986106,0.0001385236,0.0003141049,0.0007595251,0.00007301743,0.0001042743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002954,0.00002934468,0.0001442822,0.00278724,0.00006798073,0.000003713523,0.00001503967,9.864412e-8,0.000002881919,0.000001844705,0.008273309,0.9886447],"study_design_scores_gemma":[0.0001989397,0.0002733004,0.00003979403,0.004860298,0.0002679661,0.00001366605,0.000002744388,9.89108e-8,0.00003904836,0.000002400747,0.9939648,0.0003369555],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001722489,0.9969338,3.630624e-7,0.000495693,0.0001980392,0.001992384,0.0000900529,0.000007202399,0.0001101884],"genre_scores_gemma":[0.00003143453,0.9959963,0.00004142675,0.0006395868,0.001782038,0.001169673,0.0001548597,0.00007443802,0.0001102197],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9883078,"threshold_uncertainty_score":0.9999443,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2101058247","doi":"10.1016/s1470-2045(08)70107-4","title":"Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial","year":2008,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":522,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Oncolytic virus; Refractory (planetary science); Medicine; Oncology; Cancer; Liver cancer; Phases of clinical research; Cancer research; Internal medicine; Virology; Clinical trial; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1005350859476827,"gpt":0.3687444118071548,"spread":0.2682093258594721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004859136,0.0001943153,0.0005808173,0.00009119349,0.00007325679,0.000006560549,0.0003741929,0.000131748,0.0001369212],"category_scores_gemma":[0.000155029,0.0001205055,0.00006738198,0.0002568595,0.0003670799,0.00001148702,0.0001100258,0.0002732678,0.000007354486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001716286,"about_ca_system_score_gemma":0.001236394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002632859,"about_ca_topic_score_gemma":0.001908101,"domain_scores_codex":[0.9978666,0.0007235134,0.0003541073,0.0003323233,0.0002800078,0.0004434789],"domain_scores_gemma":[0.9988064,0.0001707075,0.000231019,0.0005708697,0.0001428165,0.00007825804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8919766,0.00318344,0.004813318,0.00006444583,0.0004033904,0.0001270536,0.0004618339,0.0001776542,0.07552125,0.000004244629,0.005883757,0.01738303],"study_design_scores_gemma":[0.491675,0.2058434,0.03776219,0.000114108,0.000295129,0.00006157163,0.00009706478,0.0002497303,0.08300186,0.00003163748,0.1797847,0.001083621],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975613,0.0007378978,0.00001752485,0.0002131597,0.0001022975,0.001116558,0.0001326964,0.00001078501,0.0001077197],"genre_scores_gemma":[0.995283,0.001826671,0.0005936709,0.001175014,0.0002793601,0.0002287203,0.0001411651,0.00003913014,0.0004332811],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4003016,"threshold_uncertainty_score":0.4914072,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2911914006","doi":"10.1099/jgv.0.001212","title":"ICTV Virus Taxonomy Profile: Parvoviridae","year":2019,"lang":"en","type":"article","venue":"Journal of General Virology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":521,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut National de la Recherche Scientifique; Memorial University of Newfoundland","funders":"Wellcome Trust","keywords":"Biology; Parvoviridae; Virus classification; Virology; Parvovirus; Genome; Virus; Taxonomy (biology); Genetics; Gene; Zoology","retraction":null,"screen_n_in":null,"score":{"opus":0.01863948992443171,"gpt":0.282257996428912,"spread":0.2636185065044803,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004742511,0.0001840551,0.0003208938,0.0001414302,0.00004769508,0.00002082285,0.0004663581,0.0002357204,0.0007767897],"category_scores_gemma":[0.00004477509,0.0001555056,0.0002080722,0.0001027819,0.0001010898,0.000009025844,0.0001235889,0.0003175738,0.0002044486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003092425,"about_ca_system_score_gemma":0.0002591667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008238785,"about_ca_topic_score_gemma":0.00003275276,"domain_scores_codex":[0.9984033,0.0002460036,0.0004430443,0.0002589338,0.00024007,0.0004086363],"domain_scores_gemma":[0.9989362,0.00001756672,0.0002970049,0.0003885568,0.000196141,0.0001645781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003153542,0.00008548959,0.00419874,0.000007577955,0.0001497978,0.00003284797,0.000008775059,0.0003905447,0.9760205,0.00002632323,0.01214466,0.003781154],"study_design_scores_gemma":[0.001849598,0.009783255,0.003972277,0.000005277368,0.00002166628,0.0003485319,0.00001209054,0.0001006176,0.7618578,0.00006238588,0.221766,0.000220463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954383,0.001313471,0.0002246696,0.0004880409,0.0005067021,0.0002515257,0.00001119203,0.000004659858,0.001761431],"genre_scores_gemma":[0.9920471,0.0004881748,0.001110487,0.00153244,0.001314613,0.0000190323,0.00001965394,0.00003820252,0.003430251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2141627,"threshold_uncertainty_score":0.8505302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025822934","doi":"10.1038/ncponc0736","title":"Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress","year":2007,"lang":"en","type":"review","venue":"Nature Clinical Practice Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":450,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jennerex Biotherapeutics (Canada)","funders":"","keywords":"Oncolytic virus; Virotherapy; Clinical trial; Third generation; Genetically engineered; First generation; Medicine; Cancer; Virology; Virus; Biology; Computer science; Internal medicine; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.1367214556529142,"gpt":0.5712438850854086,"spread":0.4345224294324943,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01802399,0.0007525017,0.004499401,0.0002856794,0.00007211788,0.00001965727,0.001473201,0.00816509,0.00003077758],"category_scores_gemma":[0.02151125,0.0005400933,0.001656076,0.000749146,0.002024906,0.00001664594,0.0003835579,0.006246582,0.00001880379],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001429387,"about_ca_system_score_gemma":0.008483452,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000678114,"about_ca_topic_score_gemma":0.0001061589,"domain_scores_codex":[0.9840432,0.006917935,0.005512902,0.001768395,0.0009710426,0.0007864943],"domain_scores_gemma":[0.98062,0.009685221,0.006049223,0.001948607,0.001243555,0.0004533461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.3397187,0.004179251,0.00001003566,0.001189922,0.001649352,0.0001067724,0.0000103868,2.156915e-7,0.00001430385,0.00002156993,0.001694033,0.6514055],"study_design_scores_gemma":[0.04115003,0.09594058,0.000009379321,0.001356314,0.001406544,0.0001268358,0.00002841582,9.426158e-7,0.00007563439,0.000007569372,0.8594567,0.0004410439],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001435563,0.9881532,0.00002060762,0.0004302695,0.001370561,0.005504137,0.0001618586,0.00002222314,0.002901609],"genre_scores_gemma":[0.0002820012,0.987043,0.007688183,0.0007200026,0.003245806,0.0002401086,0.0003491161,0.0001712409,0.0002605724],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8577627,"threshold_uncertainty_score":0.9997051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003955696","doi":"10.1038/sj.gt.3302036","title":"Molecular basis of the inflammatory response to adenovirus vectors","year":2003,"lang":"en","type":"review","venue":"Gene Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":427,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Biology; Adenoviridae; Innate immune system; Viral vector; Chemokine; Genetic enhancement; Transduction (biophysics); Acquired immune system; Vectors in gene therapy; Cell biology; Gene delivery; Proinflammatory cytokine; Immune system; Virology; Inflammation; Immunology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.0327122993411928,"gpt":0.3356475460909968,"spread":0.302935246749804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00118333,0.0005741499,0.0009241873,0.0002227714,0.0001045858,0.00002620396,0.001335898,0.0005189296,0.0001006937],"category_scores_gemma":[0.0001221398,0.0004109531,0.0009039886,0.00062495,0.0001601017,0.000002041765,0.0002315222,0.0003238333,0.00006363553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008489245,"about_ca_system_score_gemma":0.00121664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000519856,"about_ca_topic_score_gemma":0.00001184625,"domain_scores_codex":[0.9956684,0.001962192,0.0006243377,0.0006985273,0.0005130349,0.0005334788],"domain_scores_gemma":[0.997184,0.00005777634,0.0003023996,0.002118157,0.000153196,0.0001844466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002969034,0.00008692627,0.000009529188,0.0004478763,0.0006564608,0.00001048928,0.00004965056,0.00004236247,0.5383633,0.00000458986,0.0009480817,0.4564117],"study_design_scores_gemma":[0.0003004009,0.001087714,0.000007537697,0.0002347939,0.00003766561,0.00001321117,0.000003289737,7.937162e-8,0.3438801,0.000005162787,0.6541319,0.0002982048],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1466199,0.8515744,0.00001929349,0.0000483219,0.0002265063,0.001327996,0.00008726122,0.00001219074,0.0000841031],"genre_scores_gemma":[0.0007521626,0.9972799,0.00008498835,0.0005297271,0.0001582022,0.0002717474,0.00004167519,0.0001884748,0.0006930624],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6531838,"threshold_uncertainty_score":0.9998342,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079647238","doi":"10.1038/nrc2545","title":"Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer","year":2008,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":411,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jennerex Biotherapeutics (Canada)","funders":"","keywords":"Oncolytic virus; Cancer; Cancer therapy; Medicine; Cancer research; Computational biology; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09518882470295026,"gpt":0.4407952146786674,"spread":0.3456063899757171,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005090327,0.001015282,0.002544583,0.0001828819,0.0002205306,0.0000555249,0.000734132,0.001787801,0.00009595764],"category_scores_gemma":[0.0003030856,0.0007661907,0.0009948451,0.0004325658,0.0001603551,0.000007200237,0.0001691044,0.001255885,0.0000179449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003615907,"about_ca_system_score_gemma":0.001950392,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003711825,"about_ca_topic_score_gemma":0.0006648549,"domain_scores_codex":[0.9961749,0.0003390664,0.0009104973,0.001382262,0.0003603612,0.0008328876],"domain_scores_gemma":[0.9976886,0.0001370853,0.0006590555,0.0009456463,0.0002951486,0.0002744872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000305886,0.0001293427,0.000002185229,0.01489285,0.0008576196,0.000004026393,0.00001665542,0.000002128311,0.004380787,0.00002941308,0.003990576,0.9753885],"study_design_scores_gemma":[0.00116625,0.0006231898,0.000001423627,0.00616235,0.0008067045,0.00004011735,0.000002461722,0.00003406467,0.0006264171,0.00000895824,0.9896839,0.0008441524],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001279363,0.9917886,0.0005486628,0.00007122816,0.0006063845,0.00571674,0.00119376,0.00002832263,0.00003352711],"genre_scores_gemma":[0.00002358475,0.9871037,0.0007743305,0.001769979,0.001204735,0.007073331,0.0005079748,0.0002647695,0.001277583],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9856933,"threshold_uncertainty_score":0.9995081,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040837189","doi":"10.1089/hum.2004.15.1157","title":"The Innate Immune Response to Adenovirus Vectors","year":2004,"lang":"en","type":"review","venue":"Human Gene Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":407,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Innate immune system; Biology; Immune system; Acquired immune system; Transduction (biophysics); Adenoviridae; Immunology; Viral vector; Genetic enhancement; CCL18; Effector; Pattern recognition receptor; Immunity; Cell biology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.05521089473172554,"gpt":0.3795192086263247,"spread":0.3243083138945992,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00185469,0.0007554606,0.000931857,0.0002439046,0.0006985858,0.0001684452,0.001834629,0.0005088868,0.0001062364],"category_scores_gemma":[0.00008024598,0.0005340686,0.0007453064,0.0004496165,0.0002372398,0.000002445937,0.0003376247,0.0005055359,0.0003346692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001824449,"about_ca_system_score_gemma":0.001033711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002427739,"about_ca_topic_score_gemma":0.00006105381,"domain_scores_codex":[0.9957353,0.00124156,0.0007416654,0.000925655,0.0004859995,0.0008698219],"domain_scores_gemma":[0.9970105,0.00007761361,0.0002754191,0.002242921,0.0001503089,0.000243199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006941912,0.000124347,4.164094e-7,0.0003282414,0.0008430758,0.00003081738,0.0001139584,0.00001942457,0.3287636,0.00001822273,0.001130849,0.6616851],"study_design_scores_gemma":[0.0007803479,0.0049246,0.00001292563,0.0005126151,0.00003972476,0.00003609218,0.000007313367,5.087838e-8,0.0464967,0.00004508846,0.946534,0.0006105435],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04143015,0.9563653,0.00001066608,0.00009509987,0.0002580483,0.001663112,0.00005648866,0.0000394227,0.00008166344],"genre_scores_gemma":[0.0006017039,0.9924164,0.00003731778,0.0002360312,0.0007222169,0.0005488301,0.0002679223,0.0002861938,0.004883428],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9454032,"threshold_uncertainty_score":0.9997111,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008254103","doi":"10.1128/jvi.76.9.4580-4590.2002","title":"Differential Activation of Innate Immune Responses by Adenovirus and Adeno-Associated Virus Vectors","year":2002,"lang":"en","type":"article","venue":"Journal of Virology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":393,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale","keywords":"Chemokine; Biology; Innate immune system; Immune system; Adenoviridae; Immunology; Tumor necrosis factor alpha; Macrophage inflammatory protein; CCL5; CXCL10; Viral vector; Inflammation; Virology; Molecular biology; Genetic enhancement; T cell; Recombinant DNA; IL-2 receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.01628550941875519,"gpt":0.2769310004095062,"spread":0.2606454909907511,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002961392,0.000125505,0.0002787363,0.0001517617,0.00005262404,0.00001051656,0.0001927826,0.0002285461,0.0002071805],"category_scores_gemma":[0.0002893274,0.0001114035,0.00009292975,0.0001003411,0.0001666476,0.000008524366,0.00006684426,0.0002381045,0.000002527659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002376909,"about_ca_system_score_gemma":0.0000375511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001521424,"about_ca_topic_score_gemma":0.00001456192,"domain_scores_codex":[0.9986599,0.000361764,0.0004181319,0.0001444529,0.0001999405,0.0002158024],"domain_scores_gemma":[0.9991269,0.00006419412,0.0004277674,0.0001559174,0.0001517708,0.00007344459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005104483,0.0002121485,0.001080148,0.000005523611,0.0002133766,0.000005475385,0.0000762316,0.00001022915,0.9896042,0.000002166674,0.001141908,0.00254414],"study_design_scores_gemma":[0.001665744,0.006919626,0.010902,0.00001056154,0.00002749817,0.00003603468,0.00001753581,0.00004954083,0.979035,0.00003270775,0.001204746,0.00009896146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962298,0.003072323,0.00007605997,0.0003982788,0.00009441105,0.000069856,0.00002340892,0.000002795643,0.00003302898],"genre_scores_gemma":[0.9976209,0.001863428,0.0000174765,0.0001170904,0.00009926976,0.000002001817,0.00001070849,0.00001926235,0.0002498028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01056913,"threshold_uncertainty_score":0.4542904,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976199077","doi":"10.1093/nar/gni051","title":"Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction","year":2005,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":391,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Biology; Transgene; Cre recombinase; Genetically modified mouse; Recombinase; Gene; Embryonic stem cell; Gene expression; Transactivation; Gene targeting; Molecular biology; Cell biology; Regulation of gene expression; Genetics; Recombination","retraction":null,"screen_n_in":null,"score":{"opus":0.0625401003465286,"gpt":0.3606837535678538,"spread":0.2981436532213252,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001154624,0.0001087047,0.0001309344,0.0001528872,0.0001656714,0.00004299208,0.000167932,0.0002297687,0.00006416253],"category_scores_gemma":[0.0003888493,0.00008890322,0.00002577544,0.0003339741,0.0004263275,0.00004351798,0.0001149258,0.0004351179,0.000004796388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003712705,"about_ca_system_score_gemma":0.000103759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006213404,"about_ca_topic_score_gemma":0.0001124398,"domain_scores_codex":[0.998118,0.0005110757,0.0002552255,0.000349671,0.000479241,0.000286741],"domain_scores_gemma":[0.9992071,0.0001817811,0.00004939975,0.0002404766,0.0002543544,0.00006683272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001415656,0.0002091314,0.001664265,0.00001792087,0.00001735226,9.219668e-7,0.000312354,0.00004068813,0.989481,0.0001467841,0.0006231364,0.006070754],"study_design_scores_gemma":[0.002615192,0.001627138,0.0119142,0.0000308176,0.000003731285,0.000008295393,0.0002394805,0.0003126357,0.9702636,0.001326509,0.01152951,0.0001288893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974464,0.0005646475,0.00004590908,0.001303992,0.00005402501,0.000406494,0.00003120073,0.000005071372,0.0001422845],"genre_scores_gemma":[0.997849,0.001264899,0.0003287927,0.00005931854,0.000173671,0.00004094583,0.00014218,0.0000208014,0.0001203786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01921744,"threshold_uncertainty_score":0.3625368,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2139195068","doi":"10.1089/hum.2005.16.1241","title":"Silencing and Variegation of Gammaretrovirus and Lentivirus Vectors","year":2005,"lang":"en","type":"review","venue":"Human Gene Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":382,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Gammaretrovirus; Gene silencing; Retrovirus; Lentivirus; Provirus; Biology; Vector (molecular biology); RNA interference; Viral vector; Virology; Genetics; Gene; Virus; Genome; RNA","retraction":null,"screen_n_in":null,"score":{"opus":0.06424635041458615,"gpt":0.3672373616082265,"spread":0.3029910111936404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004234488,0.0003986447,0.0007491268,0.0001872665,0.0001320636,0.00004070779,0.0002419001,0.0003436021,0.0000708752],"category_scores_gemma":[0.00001417332,0.0003579985,0.0001912466,0.0001186158,0.0002020113,0.00000557661,0.000113595,0.0002036843,0.000004369846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003176801,"about_ca_system_score_gemma":0.0001579611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002487657,"about_ca_topic_score_gemma":0.00006365683,"domain_scores_codex":[0.9981885,0.0002757782,0.0004450836,0.0005736203,0.0002171255,0.000299885],"domain_scores_gemma":[0.9990037,0.00002988208,0.0002802074,0.0005190459,0.00006980883,0.00009734042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001476024,0.00004199775,0.00002313616,0.0005876127,0.0002477222,0.000002014369,0.00006037309,8.504355e-7,0.1335274,0.00001156486,0.00005744167,0.8652923],"study_design_scores_gemma":[0.001743765,0.005829036,0.0001770944,0.001014861,0.0002306263,0.00006662574,0.00002287787,0.000003529034,0.1869224,0.00008898646,0.802817,0.001083261],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2104577,0.7888995,0.00001547794,0.000002789192,0.0000373256,0.0004567139,0.00003450847,0.00001032204,0.00008563283],"genre_scores_gemma":[0.01636953,0.9824927,0.0000795345,0.00002968471,0.0004049937,0.00005719669,0.0002044204,0.00009074505,0.0002711929],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8642091,"threshold_uncertainty_score":0.9998872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2781931068","doi":"10.1126/scitranslmed.aam7577","title":"Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade","year":2018,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":377,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Brain Tumour Charity; Rosetrees Trust; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Oncolytic virus; Blockade; Cytotoxic T cell; Medicine; Infiltration (HVAC); Immunology; Cancer research; Virology; Biology; Virus; Internal medicine; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.02485295387765394,"gpt":0.3260394576669396,"spread":0.3011865037892856,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009646844,0.0001208008,0.0001635405,0.0001474461,0.0001485136,0.000007224468,0.0004295099,0.00004173743,0.00006760952],"category_scores_gemma":[0.0004624932,0.00009450874,0.00004924061,0.000373473,0.001351828,0.000007457058,0.00003922124,0.00006016874,0.000007880106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000514997,"about_ca_system_score_gemma":0.0007835726,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003157551,"about_ca_topic_score_gemma":0.0000751766,"domain_scores_codex":[0.9983708,0.00003433111,0.0003143928,0.0003901549,0.0005590316,0.0003313192],"domain_scores_gemma":[0.998802,0.00005108369,0.00007583346,0.0002532967,0.0006752788,0.0001425068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001871445,0.0001056037,0.0003752913,0.00001256827,0.00001656843,4.955076e-7,0.0004107473,0.00007105543,0.9903464,0.00009349771,0.00005039314,0.006645914],"study_design_scores_gemma":[0.001846299,0.01543218,0.0224042,0.00005342909,0.000009402263,0.000003263241,0.00005609075,0.00006776426,0.958252,0.0007517413,0.000994059,0.0001295668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938739,0.0002031789,0.00184968,0.003010763,0.00015283,0.0006761563,0.00002773404,0.000007528257,0.0001982513],"genre_scores_gemma":[0.9966232,0.0000114598,0.002248767,0.0007132211,0.0002685716,0.00003922433,0.00003919534,0.00001065341,0.00004569766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03209442,"threshold_uncertainty_score":0.4980865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2038691967","doi":"10.1074/jbc.m101559200","title":"Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":363,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Sialic acid; Adeno-associated virus; Biology; Receptor; Genetic enhancement; Gene delivery; Gene; Virology; Recombinant DNA; Molecular biology; Cell biology; Vector (molecular biology); Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.0605656868156984,"gpt":0.3327511771763625,"spread":0.2721854903606641,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005934261,0.0001838382,0.0003787538,0.00004456427,0.00005824581,0.00001466787,0.0004299814,0.00041719,0.0002100639],"category_scores_gemma":[0.0004872497,0.0001432051,0.0002967438,0.0002351753,0.00009064357,0.000004426618,0.00005442343,0.0001840201,0.000004783689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005117483,"about_ca_system_score_gemma":0.0001391961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001973966,"about_ca_topic_score_gemma":0.000002894554,"domain_scores_codex":[0.9985405,0.00006376275,0.000548496,0.000259485,0.000226839,0.0003609748],"domain_scores_gemma":[0.9989098,0.00003911327,0.000175444,0.000224317,0.0004417661,0.0002095052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006350496,0.0001770433,0.0005112623,0.00001691143,0.0001990808,0.0000117558,0.0000318611,0.00001436111,0.9909607,4.169498e-7,0.0007974101,0.0009287258],"study_design_scores_gemma":[0.001261114,0.004202934,0.0002123294,0.00002600861,0.00002601853,0.00004538882,0.00003686514,0.000006609187,0.9896107,0.00003763366,0.00436423,0.0001701799],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977673,0.001069119,0.0004062384,0.0003186448,0.00007742443,0.0001635838,0.00009200472,0.000006327077,0.00009937696],"genre_scores_gemma":[0.9976613,0.0008597827,0.000343139,0.0003182938,0.0003970856,0.000007641171,0.0000666272,0.00002176226,0.0003243928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005089383,"threshold_uncertainty_score":0.5839733,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3037371046","doi":"10.1186/s13045-020-00922-1","title":"Oncolytic viruses for cancer immunotherapy","year":2020,"lang":"en","type":"review","venue":"Journal of Hematology & Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":354,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Sigrid Juséliuksen Säätiö; Jane ja Aatos Erkon Säätiö; Novo Nordisk Fonden; Biomedicum Helsinki-säätiö; Finska Läkaresällskapet; Helsingin Yliopisto","keywords":"Oncolytic virus; Immunotherapy; Virotherapy; Medicine; Clinical trial; Cancer; Cancer immunotherapy; Cancer research; Virology; Immunology; Virus; Oncology; Immune system; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07781025988125306,"gpt":0.4545976021737411,"spread":0.376787342292488,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000879393,0.0005383232,0.003612032,0.0003009167,0.00008669164,0.00002118819,0.001090159,0.001266149,0.0001076942],"category_scores_gemma":[0.0003255217,0.0004254779,0.001495642,0.0002213874,0.0002859841,0.000006167518,0.0001467544,0.000823379,0.00002306576],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003049561,"about_ca_system_score_gemma":0.005730018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004333234,"about_ca_topic_score_gemma":0.0001072217,"domain_scores_codex":[0.9963558,0.0007470808,0.001568038,0.0004938084,0.0002366765,0.0005985607],"domain_scores_gemma":[0.9965295,0.0004535204,0.001889585,0.0004532501,0.0004373684,0.0002367422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003633691,0.0002530226,0.000007309726,0.002273449,0.002860335,0.00022751,0.00004199806,0.000003919035,0.003101839,0.00008798413,0.01853115,0.9689778],"study_design_scores_gemma":[0.001642524,0.01385591,2.265906e-7,0.0007863796,0.0006010677,0.002702553,0.00002178574,0.000001524968,0.002605239,0.00007892156,0.9773623,0.0003415583],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000268737,0.9965383,0.0003105714,0.0007102517,0.001031732,0.0009512033,0.00006528812,0.00001431936,0.0001096262],"genre_scores_gemma":[0.00002566828,0.9955067,0.0009437246,0.001286277,0.001551586,0.000286799,0.00002868638,0.0002042547,0.0001662873],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9686362,"threshold_uncertainty_score":0.9999066,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141797403","doi":"10.1099/0022-1317-83-5-973","title":"The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity","year":2002,"lang":"en","type":"article","venue":"Journal of General Virology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":347,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Capsid; Biology; Infectivity; Virology; Virus; Adeno-associated virus; Mutant; Gene; Molecular biology; Vector (molecular biology); Recombinant DNA; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02573642794305243,"gpt":0.2975326513213266,"spread":0.2717962233782742,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00121617,0.0002129933,0.0004065369,0.00009781827,0.0002236748,0.00002460587,0.0004346567,0.00031418,0.00008570366],"category_scores_gemma":[0.0004411711,0.0001624585,0.0002976903,0.0001951828,0.000238107,0.00001122073,0.0001038759,0.0003025851,0.000005236298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007808073,"about_ca_system_score_gemma":0.0001709787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001010311,"about_ca_topic_score_gemma":0.0006080506,"domain_scores_codex":[0.9978907,0.0004598962,0.0005979547,0.0002571093,0.0002859174,0.0005084378],"domain_scores_gemma":[0.9983113,0.00007257238,0.0006200779,0.0003844644,0.0004736368,0.0001378948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004694607,0.0002134502,0.0003134543,0.00001087817,0.0003557181,0.00001382635,0.0001354933,0.0001111738,0.9869313,0.00001984385,0.004734655,0.002465582],"study_design_scores_gemma":[0.002404955,0.00997471,0.0004245866,0.00001350318,0.00004341172,0.00005354058,0.0000195997,0.0002526482,0.9722493,0.0005735855,0.01380945,0.0001807098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933438,0.004921609,0.0001511628,0.0007689131,0.0002512267,0.0004146651,0.00006064131,0.00000495683,0.0000829663],"genre_scores_gemma":[0.9968507,0.001147345,0.0003047883,0.0005230597,0.0004460935,0.00003238923,0.000009618792,0.00004294563,0.000643054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01468202,"threshold_uncertainty_score":0.6624865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3034944349","doi":"10.1007/s00705-020-04632-4","title":"Reorganizing the family Parvoviridae: a revised taxonomy independent of the canonical approach based on host association","year":2020,"lang":"en","type":"article","venue":"Archives of Virology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":342,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland","funders":"Sigrid Juséliuksen Säätiö; Medical Research Council; Hungarian Scientific Research Fund","keywords":"Biology; Subfamily; Paraphyly; Virus classification; Parvoviridae; Evolutionary biology; Phylogenetics; Genetics; Parvovirus; Genome; Virus; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02439413002331567,"gpt":0.2471284984221239,"spread":0.2227343683988082,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003517512,0.0001205857,0.0002010916,0.0000287965,0.00007633732,0.00000620323,0.0006014699,0.0001107886,0.00001149436],"category_scores_gemma":[0.0004304741,0.00007863883,0.0001507415,0.0001232888,0.0002415164,0.000001444612,0.0001966191,0.0002681304,0.000003172523],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001282796,"about_ca_system_score_gemma":0.0002536497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002210366,"about_ca_topic_score_gemma":0.00002267619,"domain_scores_codex":[0.9983501,0.0006350364,0.0002664183,0.0002867565,0.0002318342,0.0002298031],"domain_scores_gemma":[0.9990189,0.0001858867,0.0002308663,0.0004684167,0.0000400631,0.00005587093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001850703,0.00008967256,0.006410897,0.00002124087,0.00008526474,4.186939e-7,0.0001117573,0.0007545761,0.9890237,0.00005821966,0.0005843787,0.001009103],"study_design_scores_gemma":[0.002467075,0.004659452,0.07041577,0.0000196789,0.00005906976,0.000002115439,0.0001936696,0.004805672,0.9000559,0.00005596605,0.01704095,0.0002246513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894704,0.000323367,0.001207055,0.004859932,0.00003760757,0.0005462297,0.00003501638,0.000005948516,0.003514496],"genre_scores_gemma":[0.9958587,0.00006335844,0.0003616645,0.003493746,0.00009746718,0.00004361557,0.00002152962,0.00001781647,0.00004212854],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08896783,"threshold_uncertainty_score":0.3206799,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2488203923","doi":"10.1007/s12015-016-9670-8","title":"Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments","year":2016,"lang":"en","type":"review","venue":"Stem Cell Reviews and Reports","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":324,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hendrix Genetics (Canada)","funders":"","keywords":"Green fluorescent protein; Immunogenicity; Cytotoxicity; In vivo; Biology; Cell biology; Computational biology; Gene; In vitro; Immunology; Antigen; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.0397920293565542,"gpt":0.331402690719554,"spread":0.2916106613629998,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001619705,0.0005852372,0.001672833,0.0001809475,0.00008155885,0.00007311884,0.000203648,0.0005217482,0.00005826852],"category_scores_gemma":[0.0000141716,0.0004262667,0.0003910641,0.0001567664,0.0001365174,0.000009847089,0.0002630979,0.0003134884,0.000006407364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007908009,"about_ca_system_score_gemma":0.0002574768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003409075,"about_ca_topic_score_gemma":0.00006063993,"domain_scores_codex":[0.9960111,0.0006172857,0.001509037,0.001074411,0.0002446872,0.0005434538],"domain_scores_gemma":[0.9982607,0.00002184199,0.0007438401,0.0007702392,0.00003848239,0.0001649027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000124974,0.0002463491,0.00006544199,0.01334873,0.00008191855,0.0007657222,0.00008675236,5.640284e-7,0.2495568,8.33132e-7,0.000192825,0.7355291],"study_design_scores_gemma":[0.0005600924,0.0004721486,0.00000136739,0.004685234,0.00007638392,0.0001749615,0.00003174306,7.120124e-7,0.07468583,0.000007380776,0.9187292,0.0005749562],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03000526,0.9671676,0.00002130688,0.000005140206,0.0002122462,0.001856736,0.00001199035,0.000005577985,0.0007141079],"genre_scores_gemma":[0.01183838,0.9861636,0.00002084671,0.00003110942,0.0001216713,0.000161056,0.00004457386,0.00007246538,0.001546339],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9185364,"threshold_uncertainty_score":0.9998189,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053032921","doi":"10.1016/j.molmed.2004.03.003","title":"Vesicular stomatitis virus: re-inventing the bullet","year":2004,"lang":"en","type":"review","venue":"Trends in Molecular Medicine","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":312,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Regional Cancer Foundation","funders":"","keywords":"Vesicular stomatitis virus; Vesicular Stomatitis; Virology; Virus; Biology; Interferon; Vesicular stomatitis Indiana virus; Stomatitis; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04294177511425302,"gpt":0.3803176854800436,"spread":0.3373759103657906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001325761,0.0006985228,0.001334556,0.0005106875,0.0001230973,0.00003072044,0.001179174,0.0005373078,0.000498871],"category_scores_gemma":[0.0002386461,0.0004699348,0.0005561943,0.001046149,0.0004312439,0.000002916366,0.0003105834,0.0008186311,0.00006170119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001482952,"about_ca_system_score_gemma":0.0003193646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000127359,"about_ca_topic_score_gemma":0.0003128176,"domain_scores_codex":[0.9959403,0.0007713315,0.0009053246,0.0009233493,0.0007263128,0.0007333528],"domain_scores_gemma":[0.9977192,0.00005081572,0.0003479483,0.001640925,0.00007239982,0.0001686991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007746131,0.00009863896,0.000001337142,0.002369992,0.0004664576,0.0005260688,0.0000924652,0.00004855152,0.00562468,0.00007385083,0.003654707,0.9869658],"study_design_scores_gemma":[0.001077811,0.001402713,0.00000309652,0.007449246,0.0003402938,0.00009631593,0.00003377411,0.000005155905,0.002395254,0.0000792274,0.9865987,0.0005184465],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000266637,0.9961033,0.0001898594,0.000639577,0.0002228359,0.0005323016,0.00002851298,0.00002915477,0.00198781],"genre_scores_gemma":[0.0003312833,0.9959936,0.0001595917,0.0006007724,0.0005411418,0.0002471167,0.001029454,0.0001787689,0.0009183058],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9864473,"threshold_uncertainty_score":0.9997752,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108883303","doi":"10.1038/mt.2011.276","title":"The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers","year":2011,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":308,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Terry Fox Foundation","keywords":"Oncolytic virus; Vaccinia; Biology; Virology; Cancer research; Cancer; Gene; Virus; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02357912093871324,"gpt":0.2766259929282771,"spread":0.2530468719895638,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002876326,0.0002808264,0.000235074,0.00008636753,0.0001198091,0.00004010415,0.0004537604,0.0001849883,0.00002088053],"category_scores_gemma":[0.00001678466,0.0002356015,0.00006678996,0.0003230479,0.0002223673,0.000006278196,0.00008217124,0.000279573,0.00000399701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001745963,"about_ca_system_score_gemma":0.0003328386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002173798,"about_ca_topic_score_gemma":0.003965739,"domain_scores_codex":[0.9979736,0.0003579225,0.0002852198,0.0005986911,0.0002024971,0.0005821205],"domain_scores_gemma":[0.9991303,0.00003182414,0.00009925603,0.0005488865,0.00007120126,0.0001184943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002042337,0.0001010961,0.006052459,0.00000446019,0.00009337724,0.00002298048,0.0003572446,0.0001630154,0.9707067,0.000004780761,0.0001437936,0.02030774],"study_design_scores_gemma":[0.0017075,0.001511048,0.00858574,0.00001703794,0.000004275607,0.00000437903,0.0000901156,0.0001798731,0.9860824,0.0001552475,0.001382399,0.0002799605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876504,0.01116033,0.00006834264,0.0001390259,0.00003893347,0.0007026383,0.00002687315,0.00001489636,0.0001985523],"genre_scores_gemma":[0.9890153,0.009817254,0.000123656,0.0005114566,0.00002472364,0.0003551944,0.00001618228,0.00006854141,0.00006765876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02002778,"threshold_uncertainty_score":0.9607552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090332697","doi":"10.1038/nrm827","title":"Adenovirus-5 E1A: paradox and paradigm","year":2002,"lang":"en","type":"review","venue":"Nature Reviews Molecular Cell Biology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":307,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Biology; Adenoviridae; Transcription (linguistics); Cell biology; Transcription factor; Cancer research; Gene; Genetics; Genetic enhancement; Philosophy","retraction":null,"screen_n_in":null,"score":{"opus":0.0314112104496015,"gpt":0.3500194866222386,"spread":0.3186082761726372,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00089239,0.001221165,0.002937644,0.0002942641,0.0001367643,0.0000579229,0.001123362,0.003697734,0.0001622408],"category_scores_gemma":[0.0002111021,0.0009499436,0.001214051,0.0004896253,0.0003539294,0.000004349978,0.0004931972,0.002090762,0.0004211775],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006279779,"about_ca_system_score_gemma":0.0002363664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002693291,"about_ca_topic_score_gemma":0.00000894148,"domain_scores_codex":[0.9939023,0.001905192,0.001120871,0.001848184,0.0002337552,0.000989738],"domain_scores_gemma":[0.9970446,0.00007300433,0.0006443983,0.001809044,0.00007040953,0.0003585096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005777601,0.00008118221,0.00000198055,0.005515319,0.0002466961,0.0000524332,0.000004172656,2.269121e-7,0.003661508,0.0001268193,0.003668999,0.9865829],"study_design_scores_gemma":[0.0003578392,0.001360709,1.289799e-7,0.001106713,0.0004468156,0.00009143084,8.546464e-7,0.000001228034,0.00131885,0.00007105831,0.9943224,0.0009219928],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004347267,0.9941304,0.00008619708,0.0000573784,0.0003026447,0.002318327,0.0001152704,0.00002962342,0.00291672],"genre_scores_gemma":[0.00006706467,0.9956148,0.000344777,0.0008230198,0.0005018804,0.0004303087,0.001245649,0.0001981037,0.0007744447],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9906534,"threshold_uncertainty_score":0.9992951,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2781905683","doi":"10.1126/scitranslmed.aao1641","title":"Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy","year":2018,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":295,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Children's Hospital of Eastern Ontario; McMaster University Medical Centre; Ottawa Hospital; University of Ottawa","funders":"Ontario Institute for Cancer Research; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Oncolytic virus; Medicine; Breast cancer; Triple-negative breast cancer; Virotherapy; Immune system; Immune checkpoint; Oncology; Immunity; Neoadjuvant therapy; Cancer research; Cancer; Immunotherapy; Immunology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02830103451309256,"gpt":0.3474488540167042,"spread":0.3191478195036117,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001583188,0.0002247084,0.0002856455,0.0002736882,0.0003400994,0.00002406604,0.0003677385,0.00006517211,0.0007245489],"category_scores_gemma":[0.0001050283,0.0001674476,0.0000979924,0.0009479516,0.001862124,0.00001955241,0.00002591929,0.0001190109,0.00003055435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006083352,"about_ca_system_score_gemma":0.0009915574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00029416,"about_ca_topic_score_gemma":0.0007685437,"domain_scores_codex":[0.9975216,0.00009182502,0.0003788052,0.0005926688,0.0008993815,0.0005156916],"domain_scores_gemma":[0.9986003,0.00006550344,0.00008433982,0.0003857343,0.0005898113,0.0002742964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002809331,0.00004576558,0.0009370545,0.000003849974,0.00003925273,0.000002281866,0.0008715545,0.00004034707,0.9194658,0.00001902666,0.0002113043,0.07555441],"study_design_scores_gemma":[0.00241285,0.003518408,0.100078,0.0001189514,0.000009060216,0.0000417834,0.0001635844,0.000419392,0.8902994,0.0005559479,0.002067174,0.0003154702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763344,0.0008419909,0.0006767525,0.02067328,0.0004382344,0.0006069042,0.00006782175,0.00002167647,0.0003389292],"genre_scores_gemma":[0.9956415,0.0003680865,0.0002973306,0.001784857,0.001462809,0.00006690404,0.00002938621,0.00002834904,0.0003207686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09914095,"threshold_uncertainty_score":0.7933302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087185853","doi":"10.1172/jci34316","title":"Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":284,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Genetics; James N. Kirby Foundation; National Eye Institute; National Institutes of Health; Research to Prevent Blindness; F. M. Kirby Foundation","keywords":"ABCA4; Biology; Genetic enhancement; Transduction (biophysics); Gene delivery; Retinal degeneration; Gene; Capsid; Adeno-associated virus; Retinitis pigmentosa; Vector (molecular biology); Viral vector; Virology; Genetics; Recombinant DNA","retraction":null,"screen_n_in":null,"score":{"opus":0.04523876992661468,"gpt":0.365887957769594,"spread":0.3206491878429793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003953314,0.0001154298,0.00038656,0.0002352995,0.0000224947,0.00000577106,0.0001897643,0.0002620156,0.000002718922],"category_scores_gemma":[0.002103273,0.0001101304,0.0001252579,0.0002825667,0.0001214695,0.00001948491,0.00005753574,0.0004827705,0.000001892751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000860965,"about_ca_system_score_gemma":0.0003655797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001109498,"about_ca_topic_score_gemma":0.00233426,"domain_scores_codex":[0.9967653,0.001077838,0.001384152,0.0002182557,0.0003244998,0.0002299853],"domain_scores_gemma":[0.9986346,0.0002439258,0.0006473311,0.0001364667,0.000234907,0.0001027282],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003297607,0.0002428046,0.4716313,0.000008810786,0.00003808876,0.00005141007,0.0001778899,0.001252163,0.5224999,7.81748e-7,0.00004065185,0.0007586103],"study_design_scores_gemma":[0.004094998,0.001751345,0.5057146,0.00008984148,0.000005834565,0.000007764419,0.000037156,0.0002507028,0.4878703,0.00008401856,0.00001289081,0.00008050532],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998678,0.0007646109,0.00001419308,0.000179637,0.0001237829,0.0002081037,0.00001267533,0.000001951161,0.00001707908],"genre_scores_gemma":[0.9985024,0.0009195108,0.0002028351,0.0001560468,0.0001517738,0.000004931435,0.0000266965,0.00001487913,0.00002092778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03462952,"threshold_uncertainty_score":0.4490988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987741335","doi":"10.1038/sj.mt.6300403","title":"A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas","year":2008,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":280,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre; Oncolytics Biotech (Canada); University of Calgary","funders":"","keywords":"Medicine; Virology; Pathology; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.02584841546116342,"gpt":0.3050530859248438,"spread":0.2792046704636804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002283929,0.0001841827,0.000304077,0.0001141388,0.00002986479,0.000004624487,0.0002288424,0.0001297234,0.0000282942],"category_scores_gemma":[0.00003930868,0.0001493403,0.0001007848,0.0002240011,0.0002466124,0.000004111545,0.0000246938,0.000104676,0.00000116046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002246331,"about_ca_system_score_gemma":0.0002915958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001172128,"about_ca_topic_score_gemma":0.00003021064,"domain_scores_codex":[0.9983661,0.0002490792,0.0004274358,0.0003344103,0.0003764425,0.0002465754],"domain_scores_gemma":[0.9990892,0.000009702056,0.000212753,0.0004183739,0.0001981959,0.00007179665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.3413091,0.00279229,0.0007317847,0.000008234041,0.00006118767,0.00005125477,0.00004949341,0.000008077232,0.6498374,0.00002234939,0.00002074801,0.005108114],"study_design_scores_gemma":[0.07870579,0.07913239,0.001451977,0.00001565488,0.000005483763,0.000006317034,0.000006149858,0.000007098196,0.840122,0.00002190758,0.0003631455,0.000162129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981086,0.0005962843,0.0001876082,0.00004256899,0.00005124365,0.0008850343,0.00002647801,0.000005835876,0.00009634791],"genre_scores_gemma":[0.9991781,0.0002300276,0.0002322953,0.0000677659,0.00002270805,0.00006036645,0.0001626406,0.00002326428,0.000022796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2626033,"threshold_uncertainty_score":0.6089921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1557780170","doi":"10.4161/hv.29594","title":"Pre-existing immunity against Ad vectors","year":2014,"lang":"en","type":"review","venue":"Human Vaccines & Immunotherapeutics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":277,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Immunity; Immunology; Population; Immune system; Immunization; Biology; Cellular immunity; Serotype; Acquired immune system; Virology; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07571053001266756,"gpt":0.3935280809170336,"spread":0.317817550904366,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009497969,0.001060218,0.001718552,0.0002855419,0.0005816601,0.000168482,0.0017622,0.0008857336,0.0001569431],"category_scores_gemma":[0.00007501317,0.0009643228,0.001000666,0.0003547513,0.0001380232,0.000006849874,0.0004795114,0.0009809962,0.0001318107],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001327986,"about_ca_system_score_gemma":0.0003976946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002098172,"about_ca_topic_score_gemma":0.0001345583,"domain_scores_codex":[0.9956895,0.000905447,0.001172367,0.0009224243,0.0003867551,0.0009235243],"domain_scores_gemma":[0.9963379,0.0001037022,0.0006901906,0.002475796,0.0002440676,0.0001483374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002996332,0.0002305483,0.00001381596,0.003690634,0.001267288,0.000004432732,0.00007083642,0.000007918275,0.01282747,0.0000178189,0.0004217613,0.9811478],"study_design_scores_gemma":[0.0007315336,0.001886851,0.00002861872,0.001711861,0.0003313016,0.00002117392,0.000011589,0.00000630632,0.001315919,0.00002276704,0.9929296,0.001002523],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006854433,0.9906437,0.00006374851,0.00001049816,0.0003394148,0.001043478,0.00004903449,0.00009583311,0.0008997928],"genre_scores_gemma":[0.001293486,0.9917207,0.00009088416,0.0002858019,0.0008055882,0.0001782494,0.001500256,0.00043814,0.003686928],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9925078,"threshold_uncertainty_score":0.9992808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2057672138","doi":"10.1038/sj.mt.6300215","title":"Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow","year":2007,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":277,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Oncolytic virus; Inflammation; Virus; Medicine; Immunology; Virology; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.01298807240059896,"gpt":0.273092995067845,"spread":0.2601049226672461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006704316,0.0004141627,0.0002985689,0.0001839413,0.0002295412,0.00008103802,0.0005150941,0.0002174586,0.0002195505],"category_scores_gemma":[0.0000408556,0.0004006971,0.0002448723,0.0003260471,0.0001293668,0.00001283081,0.00008053249,0.0002558549,0.00006511847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004413919,"about_ca_system_score_gemma":0.0001668895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000311179,"about_ca_topic_score_gemma":0.00008578914,"domain_scores_codex":[0.9973996,0.0002201355,0.0004489116,0.0006553033,0.00052681,0.0007492923],"domain_scores_gemma":[0.9985641,0.00002343619,0.0001556242,0.0008311465,0.0002051042,0.0002205586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007646279,0.0002379458,0.0002616205,0.00001244772,0.0003384189,0.0001361488,0.0001060696,0.0004453125,0.9759968,0.000008505172,0.00006193454,0.01474854],"study_design_scores_gemma":[0.00527159,0.00253737,0.002867017,0.00001416265,0.00001113884,0.00004674848,0.00002615505,0.0001066823,0.9828132,0.00008000607,0.005748023,0.0004779374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911443,0.005784014,0.001357872,0.0001271471,0.0001243335,0.0008826672,0.00001844655,0.00008681561,0.0004743816],"genre_scores_gemma":[0.9957989,0.00146216,0.0009083268,0.0007570494,0.0003880473,0.0000788512,0.0001647542,0.0001321586,0.0003096819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0142706,"threshold_uncertainty_score":0.9998445,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4376609298","doi":"10.1038/s41591-023-02347-y","title":"Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":270,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Clinical endpoint; Medicine; Pembrolizumab; Oncolytic virus; Oncology; Internal medicine; Hazard ratio; Phases of clinical research; Confidence interval; Clinical trial; Immunotherapy; Surgery; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02117879798470894,"gpt":0.389980995708235,"spread":0.368802197723526,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009111039,0.0002706812,0.000390998,0.0003918268,0.00006720119,0.00001197034,0.0003990874,0.0004949285,0.0002161171],"category_scores_gemma":[0.0004031396,0.0001957651,0.0001038458,0.0009419596,0.0001702889,0.000004079775,0.00008367166,0.0007913742,0.00006266406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001236473,"about_ca_system_score_gemma":0.0003302002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001663805,"about_ca_topic_score_gemma":0.0006000909,"domain_scores_codex":[0.9976902,0.0002116034,0.000372644,0.0005712754,0.0005981564,0.0005561424],"domain_scores_gemma":[0.9990086,0.00006508218,0.00008486746,0.0005657183,0.00009293028,0.0001828216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4149739,0.0004059324,0.00001805463,0.00004272676,0.00009215091,0.0001588684,0.0002872962,0.00004097126,0.5000189,0.00002517265,0.02943107,0.05450498],"study_design_scores_gemma":[0.4363909,0.1049098,0.0001727313,0.0002395621,0.00004200814,0.00004630176,0.0002372108,0.001459822,0.2458913,0.0002785162,0.2096616,0.0006703302],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899855,0.00445834,0.00002375695,0.002830778,0.0008743588,0.001048918,0.00002027634,0.00005816725,0.0006998611],"genre_scores_gemma":[0.9926767,0.001528064,0.00001448924,0.0009634568,0.002305767,0.0001844148,0.0002086385,0.00006207821,0.002056352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2541276,"threshold_uncertainty_score":0.7983069,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097849707","doi":"10.1158/0008-5472.can-12-2687","title":"Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":253,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Vaccinia; Virus; Virology; Biology; Cancer research; Cancer; Immunology; Medicine; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0403253010125256,"gpt":0.3946110424776615,"spread":0.3542857414651359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001236321,0.000200119,0.0002379168,0.0002458822,0.0001840539,0.0001153443,0.0006656797,0.000234875,0.00117554],"category_scores_gemma":[0.0003051301,0.000187239,0.0001097677,0.000718859,0.0001747746,0.00001304418,0.0003011081,0.0007767851,0.0002987249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003381999,"about_ca_system_score_gemma":0.0005895235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002038815,"about_ca_topic_score_gemma":0.01204,"domain_scores_codex":[0.996787,0.0005335727,0.0002670231,0.0006402205,0.0007271818,0.001045047],"domain_scores_gemma":[0.9984553,0.00006057745,0.00004421528,0.0007240592,0.0004774951,0.000238396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007085204,0.0001870305,0.006216187,0.00002686194,0.00008067126,0.0000222173,0.0001196211,0.00009978399,0.9795698,0.00001937914,0.009918675,0.003031271],"study_design_scores_gemma":[0.00454645,0.005585458,0.08098225,0.0001796202,0.00001333477,0.000005020211,0.0003259495,0.0003248528,0.8812419,0.0009674644,0.02497748,0.0008502338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933394,0.00326532,0.00000223586,0.0006577686,0.00007919156,0.000870709,0.00002831333,0.00001883835,0.001738203],"genre_scores_gemma":[0.9949277,0.0009202039,0.00001598655,0.0002708638,0.0002360318,0.0007917529,0.00006466176,0.00006606237,0.002706724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09832789,"threshold_uncertainty_score":0.9997375,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009994985","doi":"10.1038/nbt1060","title":"Rescue and propagation of fully retargeted oncolytic measles viruses","year":2005,"lang":"en","type":"letter","venue":"Nature Biotechnology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":251,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Oncolytic virus; Virology; Measles virus; In vivo; Antibody; Biology; In vitro; Receptor; Virus; Measles; Immunology; Vaccination","retraction":null,"screen_n_in":null,"score":{"opus":0.01206759441216013,"gpt":0.2851110805770812,"spread":0.273043486164921,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0002793822,0.0003655686,0.0004437016,0.00039831,0.00006522315,0.00001611051,0.0005825824,0.008835547,0.00003112163],"category_scores_gemma":[0.0003439781,0.0003334496,0.0001195577,0.000258701,0.000550223,0.000003662734,0.0002508941,0.003114152,0.000009685437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005495583,"about_ca_system_score_gemma":0.0002641077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001302397,"about_ca_topic_score_gemma":0.0002415945,"domain_scores_codex":[0.9979058,0.0001571933,0.0003579635,0.0007865712,0.0003445676,0.0004479266],"domain_scores_gemma":[0.9985691,0.00002652338,0.0002105555,0.0009339356,0.0002190193,0.00004082725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000609859,0.00002861164,0.00003098881,0.00009230193,0.0001696324,0.00002813664,0.000006114757,0.000002428902,0.8041823,0.00003059125,0.1845045,0.01031459],"study_design_scores_gemma":[0.0003053544,0.001360449,0.00001993926,0.00002914325,0.00002630142,0.00003004146,0.000003547318,0.0000104762,0.5447724,0.00005804563,0.4531864,0.0001978954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.4495443,0.0439091,0.00009220832,0.5039371,0.0004017545,0.001375536,0.0002220374,0.0001665424,0.000351404],"genre_scores_gemma":[0.6345186,0.008759273,0.00301624,0.3421465,0.006490789,0.0001841098,0.001944029,0.0003620353,0.002578418],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.2686819,"threshold_uncertainty_score":0.9999117,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095537460","doi":"10.1128/jvi.77.8.4646-4657.2003","title":"Ability of the Matrix Protein of Vesicular Stomatitis Virus To Suppress Beta Interferon Gene Expression Is Genetically Correlated with the Inhibition of Host RNA and Protein Synthesis","year":2003,"lang":"en","type":"article","venue":"Journal of Virology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":250,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Vesicular stomatitis virus; Biology; Interferon; Molecular biology; Mutant; Gene; Gene expression; Virus; Virology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.006935892278366709,"gpt":0.2491603795112494,"spread":0.2422244872328827,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007457752,0.000137188,0.0003176761,0.00006959835,0.00004602275,0.000006603228,0.0002676557,0.0001681866,0.00004756936],"category_scores_gemma":[0.0001769963,0.00007793926,0.0001047537,0.0001243412,0.0003903755,0.000007005754,0.000110025,0.0001946129,4.072375e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000146051,"about_ca_system_score_gemma":0.0001195503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000158501,"about_ca_topic_score_gemma":0.00002910402,"domain_scores_codex":[0.9981291,0.0007301131,0.0004948147,0.0001819675,0.0002900414,0.0001739075],"domain_scores_gemma":[0.998639,0.00004648617,0.0004954227,0.0004188529,0.0003330141,0.0000671634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003921094,0.0001511266,0.0003639431,0.00005624516,0.000107864,0.000002971697,0.0001428945,0.0001290338,0.9946682,0.000008695467,0.00006459097,0.0003833404],"study_design_scores_gemma":[0.0006548111,0.006468263,0.003495711,0.0001208744,0.00004380375,0.0000410019,0.00004486115,0.00001496214,0.9888947,0.00004810918,0.00009923972,0.00007366059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971451,0.0007154486,0.0007820473,0.0006531741,0.0000203896,0.0006225502,0.0000419659,0.000001104061,0.00001822321],"genre_scores_gemma":[0.99884,0.00006062361,0.000956247,0.00006010676,0.00002070285,0.00002534284,9.957057e-7,0.00001713053,0.00001889611],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006317136,"threshold_uncertainty_score":0.3178271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158973015","doi":"10.1086/587993","title":"Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy Adults","year":2008,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":247,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse; Center for AIDS Research, University of Washington; International AIDS Vaccine Initiative; National Institutes of Health; School of Medicine, New York University; York University","keywords":"Immunogenicity; Medicine; Virology; Adverse effect; ELISPOT; HIV vaccine; Neutralizing antibody; Placebo; Virus; Immunology; Regimen; Antibody; Vaccination; Immune system; Vaccine trial; Internal medicine; T cell","retraction":null,"screen_n_in":null,"score":{"opus":0.02940967443426321,"gpt":0.3595694906119105,"spread":0.3301598161776473,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003642624,0.0001818575,0.0004008739,0.00008078696,0.0001353311,0.000007656523,0.0002074014,0.0001894126,0.0000488035],"category_scores_gemma":[0.001002757,0.0001758248,0.0001688406,0.0002629576,0.000264486,0.000006870599,0.0001854956,0.0002334472,0.00001878966],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003933488,"about_ca_system_score_gemma":0.000352484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001199956,"about_ca_topic_score_gemma":0.0004457098,"domain_scores_codex":[0.9977052,0.0003477649,0.0008263183,0.0006431077,0.000174715,0.0003028626],"domain_scores_gemma":[0.9983041,0.0001610517,0.0002175183,0.0008769428,0.0001854561,0.0002549318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04255377,0.001854502,0.9233247,0.00009044488,0.0001801349,0.00001675432,0.00004450605,0.0001239461,0.02111384,0.00002533782,0.0007271941,0.009944868],"study_design_scores_gemma":[0.008183337,0.01383371,0.9638619,0.0000567945,0.00004177449,0.00003410473,0.0000213185,0.0001594344,0.008707691,0.0001047173,0.00464563,0.0003495506],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924912,0.006410041,0.00003279246,0.0002968905,0.0001066163,0.0004201103,0.00009055367,0.00002835557,0.0001233656],"genre_scores_gemma":[0.9835867,0.01525625,0.00001892082,0.0006624103,0.0001981859,0.000028203,0.0001569832,0.00002763768,0.00006466745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04053725,"threshold_uncertainty_score":0.7169929,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1533379125","doi":"10.1038/35087061","title":"Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1","year":2001,"lang":"en","type":"article","venue":"Nature Cell Biology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":241,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Permissiveness; Biology; Protein kinase R; Herpes simplex virus; 3T3 cells; Oncolytic virus; Virology; Kinase; Virus; Cancer cell; Cell biology; Protein kinase A; Cell culture; Transfection; Viral replication; Cancer; Genetics; Mitogen-activated protein kinase kinase","retraction":null,"screen_n_in":null,"score":{"opus":0.01337418354891114,"gpt":0.3022595400613269,"spread":0.2888853565124158,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004311719,0.0003457016,0.0003391315,0.0002031569,0.0001076889,0.00002573821,0.0005992656,0.0009522788,0.0001667247],"category_scores_gemma":[0.00007691756,0.0003140758,0.0001386549,0.000372194,0.0001068742,0.000004552988,0.000216498,0.0004639175,0.00008447257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005140068,"about_ca_system_score_gemma":0.0002290639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006975624,"about_ca_topic_score_gemma":0.001214386,"domain_scores_codex":[0.9975567,0.0003512838,0.0003252371,0.0008294055,0.0001573271,0.0007799901],"domain_scores_gemma":[0.9989755,0.00007076713,0.00008974498,0.0004783025,0.0001538542,0.0002318613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001979918,0.0001888791,0.001243315,0.00001948671,0.00002376178,0.00006435297,0.0000724274,0.0003582289,0.9734154,0.000006058059,0.0002715899,0.02235663],"study_design_scores_gemma":[0.00087987,0.001400797,0.0001962692,0.00000839004,0.000004835506,0.00000599673,0.00004893393,0.00003277892,0.7611996,0.00004671334,0.2358732,0.000302607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880592,0.008897751,0.0001738406,0.0003265259,0.0002267075,0.0004382065,0.00006851098,0.00002585093,0.001783455],"genre_scores_gemma":[0.9943775,0.001740677,0.0001888238,0.001776819,0.0004103657,0.00006522521,0.0002705218,0.00005990452,0.00111016],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2356016,"threshold_uncertainty_score":0.9999312,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102059779","doi":"10.1371/journal.pone.0050859","title":"Quantification of Reverse Transcriptase Activity by Real-Time PCR as a Fast and Accurate Method for Titration of HIV, Lenti- and Retroviral Vectors","year":2012,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":240,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"FP7 Health; National Institutes of Health; Universität Ulm; National Institute of Allergy and Infectious Diseases; Vlaamse regering; European Commission; Universiteit Gent; Fonds Wetenschappelijk Onderzoek; School of Medicine, Stanford University; University of Oxford; York University","keywords":"Reverse transcriptase; Virology; Real-time polymerase chain reaction; Biology; Titer; Human immunodeficiency virus (HIV); Molecular biology; Virus; Computational biology; Polymerase chain reaction; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.05340478434576518,"gpt":0.3185211671563403,"spread":0.2651163828105751,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004199134,0.00007684948,0.0001478746,0.0000328467,0.00003108808,0.000006293136,0.00004861971,0.00008278229,0.0000130419],"category_scores_gemma":[0.0000742573,0.00007774767,0.00003157726,0.00004932132,0.00006097299,0.0000144095,0.00001342142,0.00003996529,0.000001085749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006748849,"about_ca_system_score_gemma":0.00002865662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004963578,"about_ca_topic_score_gemma":0.00001135286,"domain_scores_codex":[0.999338,0.0001219509,0.0001291221,0.000164703,0.0001146864,0.0001314913],"domain_scores_gemma":[0.9995742,0.00002482106,0.00009250909,0.0001729097,0.00007958434,0.0000559839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00177578,0.0003880002,0.0008061176,0.0001257515,0.0001077693,3.344123e-8,0.00009228978,6.76582e-7,0.9949526,0.00001289988,0.0002268543,0.001511257],"study_design_scores_gemma":[0.0005492272,0.001097298,0.0009444809,0.00001489491,0.00006651587,4.527703e-7,0.0000246442,0.0004151742,0.9967369,0.0000121734,0.00006523683,0.00007297395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965086,0.0003275601,0.002451019,0.0001033786,0.000008115442,0.0003349835,0.0002157292,0.0000039763,0.00004663147],"genre_scores_gemma":[0.9961067,0.0004245696,0.00286992,0.00001247772,0.00003119267,0.00002387873,0.0001766667,0.00001353861,0.0003410297],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001784357,"threshold_uncertainty_score":0.3170458,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2110410873","doi":"10.1158/1078-0432.ccr-08-0524","title":"A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":239,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Carcinoembryonic antigen; Antibody; Medicine; Cancer; Antigen; Oncolytic adenovirus; Toxicity; Internal medicine; Virology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1555367822917899,"gpt":0.5162728224528756,"spread":0.3607360401610858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001304505,0.0001514362,0.0003598134,0.00015963,0.0001221886,0.00001000893,0.000421468,0.0001428973,0.0001032827],"category_scores_gemma":[0.0003676272,0.0001280263,0.00005141295,0.0007079034,0.0004081142,0.000007446728,0.0002247759,0.0006646029,0.000009190877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001342026,"about_ca_system_score_gemma":0.001220695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000987922,"about_ca_topic_score_gemma":0.005346033,"domain_scores_codex":[0.9968884,0.0005949348,0.0005236085,0.0006134784,0.0007991092,0.0005804899],"domain_scores_gemma":[0.9981924,0.0001268323,0.00009607284,0.0006300102,0.0007597405,0.0001949702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09585562,0.01294047,0.7253618,0.00005607355,0.0002566723,0.00006489219,0.0006215224,0.0007539783,0.02139501,0.000001105396,0.0003535182,0.1423394],"study_design_scores_gemma":[0.0805308,0.3274337,0.5195727,0.0002679559,0.00004176007,0.000002765945,0.000688444,0.0001464797,0.06654719,0.00002587178,0.003921972,0.0008203326],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975677,0.0009813115,0.000002164163,0.00004578202,0.00009043658,0.001130548,0.00001785521,0.000006499357,0.0001576918],"genre_scores_gemma":[0.9974642,0.001780824,0.00003029474,0.00005528691,0.0001609223,0.0002284385,0.00001372874,0.00004383371,0.000222496],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3144933,"threshold_uncertainty_score":0.5220759,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200135346","doi":"10.1016/s0140-6736(21)02753-7","title":"Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":237,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"Beijing Institute of Technology","keywords":"Immunogenicity; Interim; Interim analysis; Virology; Medicine; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Recombinant DNA; Vector (molecular biology); 2019-20 coronavirus outbreak; Clinical trial; Immunology; Internal medicine; Biology; Immune system; Outbreak; Geography","retraction":null,"screen_n_in":null,"score":{"opus":0.06440356679023261,"gpt":0.3733364001359493,"spread":0.3089328333457166,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009288007,0.0001649778,0.0008743154,0.0001880803,0.00003606952,0.00003100363,0.0003280236,0.0001014192,0.0001203152],"category_scores_gemma":[0.0002152766,0.0001319873,0.0002097463,0.0005834551,0.00008491469,0.00001143005,0.0001584196,0.0001446907,4.974601e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002667674,"about_ca_system_score_gemma":0.00009952764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003420945,"about_ca_topic_score_gemma":0.002625849,"domain_scores_codex":[0.9983073,0.000313163,0.000568365,0.0003806504,0.0002074705,0.0002229864],"domain_scores_gemma":[0.9987556,0.0001353438,0.0002736305,0.0005865344,0.00018681,0.00006208019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6337678,0.0009928425,0.001343726,0.00001112745,0.002295677,0.000004674661,0.0001684749,0.0001735314,0.3590993,0.000002712708,0.000006194726,0.002133947],"study_design_scores_gemma":[0.8615038,0.002195477,0.02159599,0.00003197145,0.0009243779,0.000004787702,0.0000929586,0.001663547,0.1116968,0.000002918971,0.0001245931,0.0001627638],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965934,0.00222896,0.00009545932,0.00009054618,0.0001033349,0.000759822,0.00009676829,0.000004580785,0.00002714399],"genre_scores_gemma":[0.9972556,0.002076361,0.0001387509,0.00003641303,0.0001080348,0.00002179113,0.0003085985,0.00001304412,0.00004143742],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2474025,"threshold_uncertainty_score":0.5382285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095394300","doi":"10.1038/mt.2011.65","title":"Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide","year":2011,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Oncolytic virus; Immune system; Immunotherapy; Virus; Biology; Medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.06545864949714603,"gpt":0.3604463169356169,"spread":0.2949876674384709,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004502251,0.0007668272,0.001150992,0.0002163702,0.000170172,0.0001315015,0.0005238461,0.0006636055,0.00006898175],"category_scores_gemma":[0.0000191769,0.0006424989,0.0003785551,0.0002238865,0.0003205825,0.000006451545,0.0001945839,0.0003802776,0.00003102194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004134711,"about_ca_system_score_gemma":0.000361345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002160261,"about_ca_topic_score_gemma":0.00001968809,"domain_scores_codex":[0.9971614,0.0005110045,0.0005003859,0.00100348,0.0002497943,0.0005739016],"domain_scores_gemma":[0.9984019,0.00003612945,0.0002417172,0.001019424,0.00008455442,0.0002163126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009522404,0.0001058883,0.000006553881,0.0006262438,0.001120492,0.00003614889,0.00005771824,2.361296e-7,0.04079192,0.00009926796,0.000155708,0.9560476],"study_design_scores_gemma":[0.001050401,0.003388064,0.000003790672,0.0006170142,0.0000937067,0.0001030093,0.00001077101,7.175685e-7,0.02125489,0.0001267083,0.9726318,0.000719191],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01159577,0.9863289,0.0001186113,0.00002319352,0.00009167969,0.00120683,0.00002562977,0.00003392933,0.0005754594],"genre_scores_gemma":[0.0005443165,0.9971485,0.0001913775,0.0008286994,0.0001542156,0.0002753848,0.00006731772,0.0002617449,0.0005284159],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.972476,"threshold_uncertainty_score":0.9996026,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159566378","doi":"10.1158/0008-5472.can-08-3873","title":"Human Bone Marrow–Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Δ24-RGD to Human Gliomas","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Massachusetts General Hospital","keywords":"Bioluminescence imaging; Oncolytic virus; Glioma; Oncolytic adenovirus; Mesenchymal stem cell; Cancer research; Medicine; Pathology; Bone marrow; Luciferase; Biology; Cell culture; Transfection; Tumor cells","retraction":null,"screen_n_in":null,"score":{"opus":0.0607782300796238,"gpt":0.3919830592821097,"spread":0.331204829202486,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00159362,0.0002634959,0.0004016457,0.0004122001,0.0003682905,0.00006492562,0.0008398448,0.0002576221,0.000171912],"category_scores_gemma":[0.00003753513,0.0002700758,0.0002287814,0.0005550421,0.0002800881,0.000009910797,0.0002440269,0.0003515925,0.00002614666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002289173,"about_ca_system_score_gemma":0.0005816341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002682733,"about_ca_topic_score_gemma":0.000665988,"domain_scores_codex":[0.9964477,0.0003474777,0.0004459799,0.0007845166,0.0009232599,0.001051105],"domain_scores_gemma":[0.9976764,0.00003991988,0.00008210006,0.0009603106,0.0008525757,0.0003887116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001924313,0.0001805608,0.00004063527,0.00009383124,0.0001282497,0.00001581401,0.0001443556,0.0001686205,0.977984,0.00005746378,0.005617004,0.01364513],"study_design_scores_gemma":[0.001625356,0.008842806,0.000237949,0.00006066605,0.0000176454,0.000003374957,0.0001526427,0.00002024788,0.9814562,0.0001122005,0.007182951,0.000287965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994164,0.003181029,0.00006387559,0.0004673792,0.00006817858,0.001561369,0.00009320585,0.00001834983,0.0003825675],"genre_scores_gemma":[0.9962912,0.0002436088,0.0001498111,0.0002239833,0.00042447,0.0003385373,0.00004269069,0.00006598712,0.002219752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01335717,"threshold_uncertainty_score":0.9999751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}